Evaluation of Natural and Botanical Medicines for Activity Against Growing and Non-growing Forms of B. burgdorferi (2020) Feng et al

JohnTheJack · Feb 22, 2020

https://www.frontiersin.org/article...m_campaign=ba-sci-fmed-botanical-lyme-disease

Lyme disease is the most common vector-borne disease in the US and Europe. Although the current recommended Lyme antibiotic treatment is effective for the majority of Lyme disease patients, about 10–20% of patients continue to suffer from persisting symptoms. There have been various anecdotal reports on the use of herbal extracts for treating patients with persisting symptoms with varying degree of improvements.

However, it is unclear whether the effect of the herb products is due to their direct antimicrobial activity or their effect on host immune system. In the present study, we investigated the antimicrobial effects of 12 commonly used botanical medicines and three other natural antimicrobial agents for potential anti-Borrelia burgdorferi activity in vitro.

Among them, 7 natural product extracts at 1% were found to have good activity against the stationary phase B. burgdorferi culture compared to the control antibiotics doxycycline and cefuroxime. These active botanicals include Cryptolepis sanguinolenta, Juglans nigra (Black walnut), Polygonum cuspidatum (Japanese knotweed), Artemisia annua (Sweet wormwood), Uncaria tomentosa (Cat's claw), Cistus incanus, and Scutellaria baicalensis (Chinese skullcap).
Click to expand...

Hutan · Feb 22, 2020

In subculture studies, only 1% Cryptolepis sanguinolenta extract caused complete eradication, while doxycycline and cefuroxime and other active herbs could not eradicate B. burgdorferi stationary phase cells as many spirochetes were visible after 21-day subculture.
Click to expand...

B. burgdorferi can evade the immune system response (15, 16) and multiple studies have shown that the bacteria is capable of persisting in diverse tissues across a variety of animal models despite aggressive and prolonged antibiotic therapy (17–19).

In addition to the mammalian studies noted above, B. burgdorferi persistence following antibiotic treatment has been demonstrated in human studies and case reports (20–23).
Click to expand...

While antibiotic retreatment has been associated with improved clinical outcomes (27, 28), antibiotic therapy appears to be more effective against the actively dividing spirochete form. In addition, it has been shown that B. burgdorferi can change morphology and form biofilm-like microcolonies consisting of stationary phase persister bacteria (29–31). Traditional antibiotics have poor activity against the atypical persister forms (round bodies, microcolonies, and biofilm) and we have previously worked to identify novel drugs and drug combinations that are effective against these atypical forms (29, 30, 32).
Click to expand...

glennthefrog · Feb 22, 2020

so now the persister forms are recognized by science? or is it that just some researches recognize them and not the CDC for example?

glennthefrog · Feb 22, 2020

found this about persisters, cited in the study referred in this post: http://www.discoverymedicine.com/Ji...-causes-severe-lyme-arthritis-in-mouse-model/
It seems today there's good evidence of the existence of said persisters...

Log in or Sign up

Evaluation of Natural and Botanical Medicines for Activity Against Growing and Non-growing Forms of B. burgdorferi (2020) Feng et al

JohnTheJack Moderator Staff Member

Hutan Moderator Staff Member

glennthefrog Established Member (Voting Rights)

glennthefrog Established Member (Voting Rights)

Share This Page

Log in or Sign up

Evaluation of Natural and Botanical Medicines for Activity Against Growing and Non-growing Forms of B. burgdorferi (2020) Feng et al

JohnTheJack Moderator Staff Member

Hutan Moderator Staff Member

glennthefrog Established Member (Voting Rights)

glennthefrog Established Member (Voting Rights)

Share This Page

Useful Searches